PriceTargets.com logo

Fortive - FTV Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $57.38
  • Forecasted Upside: 7.50%
  • Number of Analysts: 17
  • Breakdown:
  • 1 Sell Ratings
  • 13 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$53.38 As of 12/4/2025 04:59 PM ET
▼ -0.067 (-0.13%)

This chart shows the closing price for FTV by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Fortive Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for FTV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for FTV

Analyst Price Target is $57.38
▲ +7.50% Upside Potential
This price target is based on 17 analysts offering 12 month price targets for Fortive in the last 3 months. The average price target is $57.38, with a high forecast of $67.00 and a low forecast of $50.00. The average price target represents a 7.50% upside from the last price of $53.38.

This chart shows the closing price for FTV for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 17 investment analysts is to hold stock in Fortive. This rating has held steady since July 2025, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 9 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 7 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 7 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 8 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 14 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 16 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 13 hold ratings
  • 1 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 13 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/1/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
11/25/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
11/19/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
11/13/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
11/7/2025Weiss RatingsDowngradeHold (C-) ➝ Sell (D+)
11/5/2025Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$50.00 ➝ $53.00
11/4/2025Robert W. BairdBoost TargetOutperform ➝ Outperform$57.00 ➝ $58.00
10/30/2025CitigroupBoost TargetNeutral ➝ Neutral$56.00 ➝ $57.00
10/30/2025BarclaysBoost TargetEqual Weight ➝ Equal Weight$54.00 ➝ $56.00
10/30/2025JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$53.00 ➝ $55.00
10/30/2025Truist FinancialReiterated RatingHold ➝ Hold$55.00 ➝ $58.00
10/25/2025Weiss RatingsUpgradeSell (D+) ➝ Hold (C-)
10/17/2025MizuhoLower TargetOutperform ➝ Outperform$65.00 ➝ $54.00
10/15/2025JPMorgan Chase & Co.Reiterated RatingOverweight ➝ Neutral$58.00 ➝ $53.00
10/8/2025Weiss RatingsDowngradeHold (C-) ➝ Sell (D+)
9/27/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
9/15/2025Zacks ResearchUpgradeStrong Sell ➝ Hold
9/2/2025Morgan StanleyReiterated RatingOverweight ➝ Equal Weight$90.00 ➝ $50.00
8/14/2025BarclaysSet TargetOverweight ➝ Equal Weight$58.00 ➝ $54.00
8/14/2025BarclaysReiterated RatingOverweight ➝ Equal Weight$58.00 ➝ $54.00
7/31/2025Royal Bank Of CanadaLower TargetSector Perform ➝ Sector Perform$58.00 ➝ $56.00
7/31/2025Truist FinancialReiterated RatingBuy ➝ Hold$60.00 ➝ $55.00
7/22/2025Melius ResearchUpgradeHold
7/22/2025MeliusDowngradeBuy ➝ Hold$62.00
7/16/2025MizuhoLower TargetOutperform ➝ Outperform$85.00 ➝ $65.00
7/15/2025CowenDowngradeBuy ➝ Hold
7/15/2025TD CowenDowngradeBuy ➝ Hold$85.00 ➝ $50.00
7/9/2025BarclaysLower TargetOverweight ➝ Overweight$86.00 ➝ $58.00
7/2/2025JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$87.00 ➝ $65.00
7/1/2025Raymond James FinancialLower TargetOutperform ➝ Outperform$90.00 ➝ $65.00
7/1/2025Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$72.00 ➝ $55.00
6/12/2025BNP ParibasReiterated RatingNeutral ➝ Neutral
6/9/2025Royal Bank Of CanadaBoost TargetSector Perform ➝ Sector Perform$78.00 ➝ $79.00
6/3/2025BarclaysReiterated RatingOverweight ➝ Overweight$84.00 ➝ $86.00
5/16/2025JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$73.00 ➝ $87.00
5/7/2025Robert W. BairdLower TargetOutperform ➝ Outperform$88.00 ➝ $82.00
5/6/2025BarclaysLower TargetOverweight ➝ Overweight$85.00 ➝ $84.00
5/2/2025Royal Bank Of CanadaBoost TargetSector Perform ➝ Sector Perform$68.00 ➝ $72.00
4/14/2025CitigroupLower TargetNeutral ➝ Neutral$84.00 ➝ $69.00
4/9/2025BNP ParibasDowngradeOutperform ➝ Neutral$67.00
4/8/2025JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$90.00 ➝ $73.00
4/8/2025Truist FinancialLower TargetBuy ➝ Buy$90.00 ➝ $81.00
3/26/2025BarclaysLower TargetOverweight ➝ Overweight$90.00 ➝ $85.00
2/10/2025Royal Bank Of CanadaBoost TargetSector Perform ➝ Sector Perform$77.00 ➝ $85.00
2/10/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$80.00 ➝ $85.00
1/15/2025JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$92.00 ➝ $90.00
1/8/2025BarclaysLower TargetOverweight ➝ Overweight$95.00 ➝ $90.00
1/7/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$77.00 ➝ $80.00
12/19/2024Truist FinancialBoost TargetBuy ➝ Buy$89.00 ➝ $90.00
12/9/2024CitigroupDowngradeBuy ➝ Neutral$92.00 ➝ $86.00
11/18/2024ArgusReiterated RatingBuy ➝ Hold
11/13/2024UBS GroupInitiated CoverageNeutral$84.00
11/1/2024Truist FinancialLower TargetBuy ➝ Buy$90.00 ➝ $89.00
10/31/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$82.00 ➝ $77.00
10/31/2024Royal Bank Of CanadaLower TargetSector Perform ➝ Sector Perform$85.00 ➝ $77.00
10/31/2024BarclaysLower TargetOverweight ➝ Overweight$98.00 ➝ $95.00
10/10/2024JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$90.00 ➝ $92.00
10/9/2024Truist FinancialBoost TargetBuy ➝ Buy$82.00 ➝ $90.00
10/7/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$75.00 ➝ $82.00
10/2/2024BarclaysBoost TargetOverweight ➝ Overweight$96.00 ➝ $98.00
9/26/2024BarclaysBoost TargetOverweight ➝ Overweight$94.00 ➝ $96.00
9/6/2024BarclaysBoost TargetOverweight ➝ Overweight$91.00 ➝ $94.00
9/6/2024Royal Bank Of CanadaReiterated RatingSector Perform ➝ Sector Perform$77.00 ➝ $77.00
9/6/2024Morgan StanleyInitiated CoverageOverweight$89.00
9/6/2024Wolfe ResearchDowngradeOutperform ➝ Peer Perform
9/6/2024MizuhoUpgradeNeutral ➝ Outperform$80.00 ➝ $90.00
9/5/2024Raymond James FinancialUpgradeMarket Perform ➝ Outperform$85.00
7/25/2024Royal Bank Of CanadaLower TargetSector Perform ➝ Sector Perform$83.00 ➝ $77.00
7/25/2024Truist FinancialLower TargetBuy ➝ Buy$89.00 ➝ $82.00
7/25/2024BarclaysLower TargetOverweight ➝ Overweight$93.00 ➝ $91.00
7/10/2024BarclaysLower TargetOverweight ➝ Overweight$97.00 ➝ $93.00
7/10/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$84.00 ➝ $75.00
7/8/2024TD CowenUpgradeHold ➝ Buy$75.00 ➝ $90.00
7/2/2024Truist FinancialLower TargetBuy ➝ Buy$96.00 ➝ $89.00
4/25/2024CitigroupLower TargetBuy ➝ Buy$101.00 ➝ $98.00
4/25/2024Royal Bank Of CanadaLower TargetSector Perform ➝ Sector Perform$93.00 ➝ $83.00
4/25/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$92.00 ➝ $84.00
4/17/2024JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$95.00 ➝ $90.00
4/8/2024CitigroupBoost TargetBuy ➝ Buy$90.00 ➝ $101.00
4/2/2024BarclaysBoost TargetOverweight ➝ Overweight$89.00 ➝ $97.00
3/14/2024Truist FinancialInitiated CoverageBuy$99.00
2/1/2024MizuhoBoost TargetNeutral ➝ Neutral$70.00 ➝ $80.00
2/1/2024Royal Bank Of CanadaBoost TargetSector Perform ➝ Sector Perform$75.00 ➝ $80.00
2/1/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$83.00 ➝ $87.00
2/1/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$79.00 ➝ $85.00
1/2/2024Vertical ResearchDowngradeBuy ➝ Hold
12/19/2023Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$70.00 ➝ $79.00
10/26/2023Royal Bank Of CanadaLower TargetSector Perform ➝ Sector Perform$79.00 ➝ $73.00
10/26/2023MizuhoLower TargetNeutral ➝ Neutral$70.00 ➝ $66.00
10/26/2023BarclaysLower TargetOverweight ➝ Overweight$83.00 ➝ $76.00
10/26/2023Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$75.00 ➝ $70.00
10/26/2023Bank of AmericaDowngradeBuy ➝ Neutral$70.00
10/10/2023UBS GroupBoost TargetBuy ➝ Buy$80.00 ➝ $90.00
10/9/2023Wells Fargo & CompanyLower Target$79.00 ➝ $75.00
10/5/2023BNP ParibasInitiated CoverageOutperform$91.00
8/23/2023TD CowenBoost TargetMarket Perform ➝ Market Perform$70.00 ➝ $72.00
8/7/2023Seaport Res PtnReiterated RatingBuy
7/27/2023CitigroupBoost TargetBuy$85.00 ➝ $90.00
7/27/2023ArgusBoost Target$80.00 ➝ $85.00
7/27/2023Robert W. BairdBoost Target$82.00 ➝ $85.00
7/27/2023MizuhoBoost Target$63.00 ➝ $70.00
7/27/2023BarclaysBoost TargetOverweight$77.00 ➝ $83.00
7/10/2023Wells Fargo & CompanyBoost Target$67.00 ➝ $71.00
7/10/2023BarclaysBoost Target$72.00 ➝ $77.00
7/10/2023CitigroupBoost Target$78.00 ➝ $85.00
5/26/2023Royal Bank Of CanadaBoost Target$74.00 ➝ $75.00
4/27/2023JPMorgan Chase & Co.Boost Target$77.00 ➝ $78.00
4/13/2023Wells Fargo & CompanyLower TargetEqual Weight$70.00 ➝ $68.00
3/27/2023Vertical ResearchUpgradeHold ➝ Buy$74.00
2/2/2023Wells Fargo & CompanyBoost TargetEqual Weight$69.00 ➝ $70.00
2/2/2023CitigroupBoost TargetBuy$77.00 ➝ $78.00
2/2/2023JPMorgan Chase & Co.Boost TargetOverweight$74.00 ➝ $77.00
1/19/2023Wells Fargo & CompanyBoost TargetEqual Weight$67.00 ➝ $69.00
1/13/2023MizuhoBoost TargetNeutral$60.00 ➝ $63.00
1/5/2023Wells Fargo & CompanyBoost TargetEqual Weight$64.00 ➝ $67.00
12/9/2022CitigroupBoost TargetBuy$73.00 ➝ $77.00
10/27/2022Credit Suisse GroupLower TargetOutperform$79.00 ➝ $78.00
10/27/2022Wells Fargo & CompanyBoost TargetEqual Weight$63.00 ➝ $64.00
10/27/2022Morgan StanleyBoost TargetOverweight$73.00 ➝ $75.00
10/12/2022Morgan StanleyUpgradeEqual Weight ➝ Overweight$68.00 ➝ $73.00
10/10/2022CitigroupBoost Target$72.00 ➝ $73.00
8/9/2022BarclaysBoost Target$72.00
8/1/2022BarclaysBoost TargetOverweight$68.00 ➝ $72.00
8/1/2022Wells Fargo & CompanyBoost TargetEqual Weight$57.00 ➝ $63.00
7/29/2022Royal Bank Of CanadaBoost Target$61.00 ➝ $68.00
7/29/2022Morgan StanleyBoost TargetEqual Weight$64.00 ➝ $68.00
7/29/2022Robert W. BairdLower Target$81.00 ➝ $77.00
7/29/2022CitigroupBoost Target$69.00 ➝ $72.00
7/19/2022Credit Suisse GroupSet Target$74.00
7/19/2022Loop CapitalLower TargetBuy$84.00 ➝ $78.00
7/18/2022MizuhoLower TargetNeutral$62.00 ➝ $60.00
7/12/2022Wells Fargo & CompanyLower TargetEqual Weight$58.00 ➝ $57.00
7/8/2022BarclaysLower TargetOverweight$74.00 ➝ $68.00
6/29/2022Wells Fargo & CompanyLower TargetEqual Weight$65.00 ➝ $58.00
6/2/2022CowenLower TargetMarket Perform$80.00 ➝ $70.00
6/2/2022CowenLower Target$80.00 ➝ $70.00
5/31/2022Morgan StanleyLower TargetEqual Weight$67.00 ➝ $64.00
4/7/2022Morgan StanleyLower TargetEqual Weight$76.00 ➝ $70.00
3/17/2022ArgusUpgradeHold ➝ Buy$68.00
3/14/2022BarclaysUpgradeEqual Weight ➝ Overweight$75.00
2/7/2022Morgan StanleyLower TargetEqual Weight$82.00 ➝ $76.00
2/4/2022Credit Suisse GroupLower TargetOutperform$90.00 ➝ $88.00
2/4/2022JPMorgan Chase & Co.Lower Target$98.00 ➝ $95.00
2/4/2022Robert W. BairdLower Target$86.00 ➝ $81.00
2/4/2022CitigroupLower Target$99.00 ➝ $91.00
1/4/2022BarclaysBoost TargetEqual Weight$75.00 ➝ $76.00
1/3/2022Vertical ResearchDowngradeBuy ➝ Hold$82.00
12/16/2021MizuhoInitiated CoverageNeutral$82.00
11/22/2021Loop CapitalInitiated CoverageBuy$90.00
10/29/2021Morgan StanleyBoost TargetEqual Weight$78.00 ➝ $82.00
10/29/2021Royal Bank Of CanadaBoost TargetSector Perform$75.00 ➝ $77.00
10/29/2021Credit Suisse GroupBoost TargetOutperform$84.00 ➝ $87.00
10/7/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$72.00
7/30/2021Morgan StanleyLower TargetEqual Weight$81.00 ➝ $78.00
7/30/2021Royal Bank Of CanadaLower TargetSector Perform$78.00 ➝ $74.00
7/12/2021Wolfe ResearchUpgradePeer Perform ➝ Outperform$81.00 ➝ $84.00
5/20/2021Credit Suisse GroupLower TargetOutperform$81.00 ➝ $80.00
5/20/2021Royal Bank Of CanadaLower TargetNeutral ➝ Sector Perform$79.00 ➝ $75.00
5/20/2021JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$70.00 ➝ $80.00
5/4/2021Rosenblatt SecuritiesBoost TargetNeutral$71.00 ➝ $72.00
4/30/2021Morgan StanleyBoost TargetEqual Weight$76.00 ➝ $81.00
4/12/2021Morgan StanleyBoost TargetEqual Weight$75.00 ➝ $76.00
4/6/2021BarclaysBoost TargetEqual Weight$72.00 ➝ $73.00
2/17/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$75.00 ➝ $75.00
2/5/2021CitigroupBoost TargetBuy$83.00 ➝ $85.00
1/20/2021Morgan StanleyBoost TargetOverweight$74.00 ➝ $75.00
12/8/2020Wolfe ResearchDowngradeOutperform ➝ Peer Perform$71.00 ➝ $78.00
12/4/2020UBS GroupInitiated CoverageBuy$83.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

1.46 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 39 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 37 very positive mentions
  • 21 positive mentions
  • 4 negative mentions
  • 2 very negative mentions
Mentions as of
7/7/2025
  • 40 very positive mentions
  • 25 positive mentions
  • 4 negative mentions
  • 2 very negative mentions
Mentions as of
8/6/2025
  • 71 very positive mentions
  • 15 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 46 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 49 very positive mentions
  • 28 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 64 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 64 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Fortive logo
Fortive Corporation designs, develops, manufactures, and services professional and engineered products, software, and services in the United States, China, and internationally. It operates in three segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including electrical test and measurement, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. The Precision Technologies segment offers electrical test and measurement, sensing and material technologies for industrial, power and energy, automotive, medical equipment, food and beverage, aerospace and defense, semiconductor, and other general industries under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, design and manufacture of cell therapy equipment, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, PROVATION, RAYSAFE, and STERRAD brands. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
Read More

Today's Range

Now: $53.38
Low: $53.10
High: $53.82

50 Day Range

MA: $50.61
Low: $47.87
High: $53.48

52 Week Range

Now: $53.38
Low: $46.34
High: $83.32

Volume

2,570,386 shs

Average Volume

2,890,655 shs

Market Capitalization

$16.95 billion

P/E Ratio

30.50

Dividend Yield

0.45%

Beta

1.13

Frequently Asked Questions

What sell-side analysts currently cover shares of Fortive?

The following equities research analysts have issued stock ratings on Fortive in the last twelve months: Barclays PLC, BNP Paribas, Citigroup Inc., Cowen Inc, JPMorgan Chase & Co., Melius, Melius Research, Mizuho, Morgan Stanley, Raymond James Financial, Inc., Robert W. Baird, Royal Bank Of Canada, TD Cowen, Truist Financial Corporation, Wall Street Zen, Weiss Ratings, Wells Fargo & Company, and Zacks Research.
View the latest analyst ratings for FTV.

What is the current price target for Fortive?

0 Wall Street analysts have set twelve-month price targets for Fortive in the last year. Their average twelve-month price target is $57.38, suggesting a possible upside of 7.5%. BNP Paribas has the highest price target set, predicting FTV will reach $67.00 in the next twelve months. TD Cowen has the lowest price target set, forecasting a price of $50.00 for Fortive in the next year.
View the latest price targets for FTV.

What is the current consensus analyst rating for Fortive?

Fortive currently has 1 sell rating, 13 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in FTV, but not buy more shares or sell existing shares.
View the latest ratings for FTV.

What other companies compete with Fortive?

Other companies that are similar to Fortive include Nordson, AMETEK, Donaldson, Dover and IDEX. Learn More about companies similar to Fortive.

How do I contact Fortive's investor relations team?

Fortive's physical mailing address is 6920 SEAWAY BLVD., EVERETT WA, 98203. The technology company's listed phone number is (425) 446-5000 and its investor relations email address is [email protected]. The official website for Fortive is www.fortive.com. Learn More about contacing Fortive investor relations.